Market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights are among the key offerings featured in The Business Research Company’s 2026 market reports, designed to deliver more actionable and strategically valuable research.
Drug Discovery Informatics Market On Course To Reach $7.74 Billion By 2030: Size And Growth Overview
The drug discovery informatics market size has expanded swiftly in recent years. This market is anticipated to increase from $4.06 billion in 2025 to $4.63 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.1%. The historical growth of the market can be linked to factors including increasing pharmaceutical R&D complexity, the expansion of clinical trial data volumes, the adoption of computational chemistry tools, growth in bioinformatics applications, and a rising demand for faster drug development cycles.
The drug discovery informatics market is projected to experience substantial expansion over the coming years. Its valuation is anticipated to reach $7.74 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.7%. This anticipated growth is driven by several factors, including escalating investments in AI-powered drug discovery, the increasing uptake of precision medicine strategies, the proliferation of collaborative research platforms, an intensified focus on enhancing predictive modeling accuracy, and the greater integration of informatics with existing laboratory systems. Key developments expected during this timeframe encompass the wider deployment of AI-driven drug discovery platforms, a surge in the adoption of cloud-based informatics solutions, the deeper incorporation of big data analytics into research and development efforts, an expansion of virtual screening and modeling capabilities, and an elevated emphasis on robust data integration and management.
Need Drug Discovery Informatics Market Forecasts? Get Your Free Sample Report Here:
Drug Discovery Informatics Market Growth Factors: What Is Strengthening Demand Worldwide?
An increase in chronic diseases is anticipated to drive the expansion of the drug discovery informatics market in the future. Generally, chronic illnesses are defined as conditions lasting a year or more, requiring ongoing medical attention, interfering with daily life, or both. These informatics systems facilitate progress in managing chronic conditions by enabling scientists to investigate intricate and temporary molecular alterations underlying disease development and drug reactions, leading to comprehensive multi-dimensional models of the complete biological system across healthy, sick, and treated conditions. For example, in May 2024, the British Diabetic Association (Diabetes UK), a UK-based charity supporting patients, healthcare professionals, and research, reported that approximately 4.4 million individuals in the UK had been diagnosed with diabetes by 2022-23. Of these instances, roughly 8% suffered from type 1 diabetes, with type 2 diabetes making up around 90%. Consequently, the growing occurrence of diverse chronic diseases is fueling the expansion of the drug discovery informatics market.
Drug Discovery Informatics Market By Segment: Complete Category And Subcategory Breakdown
The drug discovery informatics market covered in this report is segmented –
1) By Service: In-House, Outsourced
2) By Application: Data Sequencing, Molecular Docking, Identification And Validation, Target Data Analysis
3) By End-User: Pharmaceutical Companies, Contract Research Organizations, Bio-Technology Companies
Subsegments:
1) By In-House: Data Management, Computational Chemistry, Bioinformatics, Cheminformatics, Predictive Modeling
2) By Outsourced: Contract Research Organizations (CROs), Specialized Informatics Providers, Data Analysis And Management Services
Drug Discovery Informatics Market Trend Outlook: Developments Defining The Forecast Period
Major companies operating in the drug discovery informatics market are strategically focusing on innovative products, such as AI-powered life sciences solutions, to enhance their market revenues. Artificial intelligence (AI)-driven life sciences solutions are actively advancing precision medicine and drug discovery, possessing the capacity to entirely transform the creation of novel therapies and individualized treatment plans. This transformation aims to improve the speed, precision, and efficiency of the life sciences industry’s research and development procedures. For instance, in May 2023, Google Cloud Platform, a US-based technology company, unveiled AI-powered life sciences solutions, specifically a target and lead identification suite, and a multiomics suite. These solutions are intended to revolutionize life sciences companies by speeding up drug research and accelerating the release of new treatments. These methods anticipate protein structures, determine the role of amino acids, and analyze genetic data by utilizing high-performance computers, generative AI, and sophisticated computational tools. The multiomics suite supports the development of precision medicine tools, while the target and lead identification suite facilitates more effective in silico drug design.
Who Is Competing For Share In The Drug Discovery Informatics Market?
Major companies operating in the drug discovery informatics market are Accenture Plc.; Certara Inc.; Charles River Laboratories Inc.; Infosys Ltd.; Collaborative Drug Discovery Inc.; Eurofins DiscoverX Products Inc.; Jubilant Biosys Ltd.; Selvita S.A.; PerkinElmer Inc.; International Business Machines Corporation; Boehringer Ingelheim International GmbH; Oracle Corporation; Thermo Fisher Scientific Inc.; Albany Molecular Research Inc.; ChemAxon Ltd.; Amazon Web Services Inc.; Schrödinger LLC.; Core Informatics LLC; Informatics Matters Ltd.; Tata Consultancy Services Limited; Novo Informatics Pvt. Ltd.; IO Informatics Inc.; GVK Biosciences Private Limited; Dassault Systèmes SE; Recursion Pharmaceuticals Inc.; Cyclica Inc.; Valence Discovery Inc.; Valo Health Inc.; Cognizant Technology Solutions Corporation; Wipro Limited; Mindtree Limited; Persistent Systems Limited; Mphasis Limited
Get The Full Picture With The Drug Discovery Informatics Market Report:
Drug Discovery Informatics Market Regional Snapshot: Leading Geography In 2025
North America was the largest region in the drug discover informatics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the drug discovery informatics market during the forecast period. The regions covered in the drug discovery informatics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
